China Traditional Chinese Medicine Holdings Past Earnings Performance
Past criteria checks 2/6
China Traditional Chinese Medicine Holdings's earnings have been declining at an average annual rate of -10.8%, while the Pharmaceuticals industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 5.4% per year. China Traditional Chinese Medicine Holdings's return on equity is 4.1%, and it has net margins of 5.3%.
Key information
-10.8%
Earnings growth rate
-10.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 5.6% |
| Revenue growth rate | 5.4% |
| Return on equity | 4.1% |
| Net Margin | 5.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable
Jan 04
Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?
Oct 23Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Aug 23Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?
May 22China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year
Dec 08These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively
Sep 05China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially
Jul 20Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Jul 18Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock
Jun 01Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly
Apr 28Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Feb 14Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock
Jan 11Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly
Dec 05China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate
Oct 29I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease
Oct 11These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Reasonably Well
Aug 24Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?
Jul 13China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jun 25Does China Traditional Chinese Medicine Holdings (HKG:570) Deserve A Spot On Your Watchlist?
Apr 04Are Investors Undervaluing China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) By 30%?
Mar 15China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 22China Traditional Chinese Medicine Holdings (HKG:570) Shareholders Have Enjoyed A 19% Share Price Gain
Feb 01What Percentage Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Do Insiders Own?
Dec 18Is China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Trading At A 33% Discount?
Dec 03
Declining Stock and Decent Financials: Is The Market Wrong About China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)?
Nov 18Revenue & Expenses Breakdown
How China Traditional Chinese Medicine Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 17,204 | 917 | 7,180 | 640 |
| 31 Mar 24 | 17,663 | 1,101 | 7,318 | 663 |
| 31 Dec 23 | 18,122 | 1,285 | 7,457 | 686 |
| 30 Sep 23 | 17,909 | 1,107 | 7,280 | 647 |
| 30 Jun 23 | 17,696 | 930 | 7,102 | 608 |
| 31 Mar 23 | 16,000 | 847 | 6,331 | 610 |
| 31 Dec 22 | 14,304 | 764 | 5,559 | 612 |
| 30 Sep 22 | 15,560 | 1,091 | 6,411 | 665 |
| 30 Jun 22 | 16,815 | 1,417 | 7,262 | 717 |
| 31 Mar 22 | 17,934 | 1,675 | 7,917 | 706 |
| 31 Dec 21 | 19,053 | 1,933 | 8,572 | 694 |
| 30 Sep 21 | 17,677 | 1,897 | 7,781 | 647 |
| 30 Jun 21 | 16,300 | 1,861 | 6,990 | 600 |
| 31 Mar 21 | 15,553 | 1,762 | 6,662 | 575 |
| 31 Dec 20 | 14,806 | 1,663 | 6,334 | 550 |
| 30 Sep 20 | 14,423 | 1,562 | 6,074 | 525 |
| 30 Jun 20 | 14,039 | 1,461 | 5,814 | 500 |
| 31 Mar 20 | 14,180 | 1,525 | 5,813 | 482 |
| 31 Dec 19 | 14,321 | 1,588 | 5,813 | 464 |
| 30 Sep 19 | 13,528 | 1,563 | 5,391 | 435 |
| 30 Jun 19 | 12,735 | 1,538 | 4,970 | 406 |
| 31 Mar 19 | 11,997 | 1,488 | 4,424 | 376 |
| 31 Dec 18 | 11,259 | 1,439 | 3,877 | 347 |
| 30 Sep 18 | 10,579 | 1,386 | 3,586 | 288 |
| 30 Jun 18 | 9,900 | 1,332 | 3,295 | 230 |
| 31 Mar 18 | 9,119 | 1,251 | 3,032 | 216 |
| 31 Dec 17 | 8,338 | 1,170 | 2,768 | 202 |
| 30 Sep 17 | 7,785 | 1,123 | 2,595 | 205 |
| 30 Jun 17 | 7,233 | 1,075 | 2,422 | 208 |
| 31 Mar 17 | 6,883 | 1,021 | 2,360 | 198 |
| 31 Dec 16 | 6,533 | 967 | 2,298 | 187 |
| 30 Sep 16 | 6,010 | 880 | 2,147 | 184 |
| 30 Jun 16 | 5,487 | 794 | 1,995 | 181 |
| 31 Mar 16 | 4,598 | 670 | 1,732 | 147 |
| 31 Dec 15 | 3,709 | 546 | 1,468 | 112 |
| 30 Sep 15 | 3,271 | 509 | 1,309 | 72 |
| 30 Jun 15 | 2,833 | 471 | 1,151 | 32 |
| 31 Mar 15 | 2,742 | 444 | 1,138 | 16 |
| 31 Dec 14 | 2,650 | 417 | 1,125 | 0 |
| 30 Sep 14 | 2,384 | 370 | 999 | 0 |
| 30 Jun 14 | 2,117 | 324 | 872 | 0 |
| 31 Mar 14 | 1,756 | 261 | 725 | 0 |
| 31 Dec 13 | 1,395 | 198 | 577 | 0 |
Quality Earnings: 570 has high quality earnings.
Growing Profit Margin: 570's current net profit margins (5.3%) are higher than last year (5.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 570's earnings have declined by 10.8% per year over the past 5 years.
Accelerating Growth: 570's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 570 had negative earnings growth (-1.3%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (9.4%).
Return on Equity
High ROE: 570's Return on Equity (4.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 11:40 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Traditional Chinese Medicine Holdings Co. Limited is covered by 25 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ling Zhang | BNP Paribas Securities (Asia) |
| Yue-Kwong Lui | BOCOM International Securities Limited |
| Helena Qiu | CCB International Securities Limited |